Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,584 across all filing types
Latest filing 2021-08-17 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
Director's Dealing 2021
Director's Dealing
2021-08-17 English
Director's Dealing 2021
Director's Dealing
2021-08-13 English
10-Q
Interim / Quarterly Report Q2 2021
2021-08-06 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and states that a press release and investor presentation regarding the second quarter results are furnished as exhibits. The document itself does not contain detailed financial statements or substantive financial data but rather references and attaches a press release and an investor presentation. The length of the document is 4210 characters, which is relatively short and consistent with a current report rather than a full financial report. According to the rules, a Form 8-K announcing quarterly results and attaching a press release and presentation is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights only, not a full interim report (IR).
2021-08-05 English
Director's Dealing 2021
Director's Dealing
2021-07-28 English
Director's Dealing 2021
Director's Dealing
2021-07-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.